TGF-β: The sword, the wand, and the shield of FOXP3 + regulatory T cells

Journal of Molecular Cell Biology

Volumn 4, Issue 1, 2012, Pages 29-37

  Tran, Dat Q ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

autoimmunity; Foxp3; GARP; LAP; LRRC32; TGF ; tolerance; transplantation; Tregs

Indexed keywords

T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFECTION; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL LYMPHOCYTE; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TH17 CELL; THYMOCYTE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL MEMBRANE; FORKHEAD TRANSCRIPTION FACTORS; HOMEOSTASIS; HUMANS; INFLAMMATION; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION TOLERANCE;

EID: 84856945806     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjr033     Document Type: Review

References (96)

1. + regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J. Exp. Med. 205, 1975-1981.
2. Annes, J.P., Munger, J.S., and Rifkin, D.B. (2003). Making sense of latent TGFbeta activation. J. Cell Sci. 116, 217-224. (Pubitemid 36163863)
3. Bailey-Bucktrout, S.L., and Bluestone, J.A. (2011). Regulatory T cells: Stability revisited. Trends Immunol. 32, 301-306.
4. Brunkow, M.E., Jeffery, E.W., Hjerrild, K.A., et al. (2001). Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73. (Pubitemid 32044521)
5. Chen, M.L., Pittet, M.J., Gorelik, L., et al. (2005). Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc. Natl Acad. Sci. USA 102, 419-424. (Pubitemid 40116782)
6. + regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 34, 409-421.
7. + regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 172, 6003-6010. (Pubitemid 38621201)
8. + effector T cells. Nat. Immunol. 9, 1347-1355.
9. Dardalhon, V., Korn, T., Kuchroo, V.K., et al. (2008b). Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun. 31, 252-256.
10. + regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J. Exp. Med. 196, 247-253. (Pubitemid 34787514)
11. + T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells. J. Immunol. 175, 7135-7142. (Pubitemid 41713406)
12. + regulatory T cells: Differentiation, specification, subphenotypes. Nat. Immunol. 10, 689-695.
13. + regulatory T cells. Nat. Immunol. 4, 330-336. (Pubitemid 36432314)
14. + T cell immune response by the cytokine TGFbeta. PLoS One 5, e12281.
15. Gershon, R.K., and Kondo, K. (1971). Infectious immunological tolerance. Immunology 21, 903-914.
16. + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J. Exp. Med. 202, 1075-1085. (Pubitemid 41464501)
17. Ghoreschi, K., Laurence, A., Yang, X.P., et al. (2010). Generation of pathogenic TH17 cells in the absence of TGF-beta signalling. Nature 467, 967-971.
18. Gil-Guerrero, L., Dotor, J., Huibregtse, I.L., et al. (2008). In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1. J. Immunol. 181, 126-135.
19. Glinka, Y., and Prud'homme, G.J. (2008). Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J. Leukoc. Biol. 84, 302-310. (Pubitemid 351960305)
20. Gorelik, L., and Flavell, R.A. (2000). Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171-181. (Pubitemid 30398631)
21. Gorelik, L., and Flavell, R.A. (2002). Transforming growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2, 46-53. (Pubitemid 37328775)
22. Gutcher, I., Donkor, M.K., Ma, Q., et al. (2011). Autocrine transforming growth factor-beta1 promotes in vivo Th17 cell differentiation. Immunity 34, 396-408.
23. Heldin, C.H., Miyazono, K., and ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471. (Pubitemid 28013118)
24. Hori, S. (2011). Regulatory T cell plasticity: Beyond the controversies. Trends Immunol. 32, 295-300.
25. Huse, M., Muir, T.W., Xu, L., et al. (2001). The TGF beta receptor activation process: An inhibitor- to substrate-binding switch. Mol. Cell 8, 671-682. (Pubitemid 32946943)
26. + T helper cells. J. Exp. Med. 196, 255-260. (Pubitemid 34787515)
27. Kehrl, J.H., Wakefield, L.M., Roberts, A.B., et al. (1986). Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163, 1037-1050. (Pubitemid 16000407)
28. Korn, T., Bettelli, E., Oukka, M., et al. (2009). IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517.
29. Kozawa, O., Blume-Jensen, P., Heldin, C.H., et al. (1997). Involvement of phosphatidylinositol 3'-kinase in stem-cell-factor-induced phospholipase D activation and arachidonic acid release. Eur. J. Biochem. 248, 149-155. (Pubitemid 27356982)
30. Lawrence, D.A. (2001). Latent-TGF-beta: An overview. Mol. Cell. Biochem. 219, 163-170.
31. Leibund Gut-Landmann, S., Gross, O., Robinson, M.J., et al. (2007). Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8, 630-638. (Pubitemid 46785127)
32. Leveen, P., Larsson, J., Ehinger, M., et al. (2002). Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood 100, 560-568. (Pubitemid 34761120)
33. Li, M.O., and Flavell, R.A. (2008). TGF-beta: A master of all T cell trades. Cell 134, 392-404.
34. Li, M.O., Sanjabi, S., and Flavell, R.A. (2006). Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25, 455-471. (Pubitemid 44354214)
35. Li, M.O., Wan, Y.Y., and Flavell, R.A. (2007). T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26, 579-591. (Pubitemid 46756347)
36. + regulatory T cells. Nat. Immunol. 9, 632-640. (Pubitemid 351712634)
37. Lohr, J., Knoechel, B., Wang, J.J., et al. (2006). Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J. Exp.Med. 203, 2785-2791. (Pubitemid 46026156)
38. Macaulay, I.C., Tijssen, M.R., Thijssen-Timmer, D.C., et al. (2007). Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood 109, 3260-3269. (Pubitemid 46572511)
39. + regulatory T cells. J. Exp. Med. 201, 1061-1067. (Pubitemid 40524674)
40. Marie, J.C., Liggitt, D., and Rudensky, A.Y. (2006). Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25, 441-454. (Pubitemid 44354215)
41. Mempel, T.R., Pittet, M.J., Khazaie, K., et al. (2006). Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25, 129-141. (Pubitemid 44066829)
42. + regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194, 629-644. (Pubitemid 32844773)
43. O'Connor, M.N., Salles, I.I., Cvejic, A., et al. (2009). Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins. Blood 113, 4754-4762.
44. + T cells is facilitated by CTLA-4 signaling. J. Immunol. 177, 2331-2339. (Pubitemid 44200993)
45. Ostroukhova, M., Qi, Z., Oriss, T.B., et al. (2006). Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J. Clin. Invest. 116, 996-1004.
46. Ouyang, W., Beckett, O., Ma, Q., et al. (2010). Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 32, 642-653.
47. + T cells. Immunity 25, 249-259. (Pubitemid 44224144)
48. + T cells. Nat. Immunol. 8, 1353-1362. (Pubitemid 350131172)
49. + regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34, 422-434.
50. Pesu, M., Watford, W.T., Wei, L., et al. (2008). T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature 455, 246-250.
51. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 196, 237-246.
52. + T cells. J. Exp. Med. 183, 2669-2674.
53. Probst-Kepper, M., Geffers, R., Kroger, A., et al. (2009). GARP: A key receptor controlling FOXP3 in human regulatory T cells. J. Cell. Mol. Med. 13, 3343-3357.
54. - T cells anergic and suppressive. Immunology 120, 447-455. (Pubitemid 46365018)
55. Qin, S., Cobbold, S.P., Pope, H., et al. (1993). 'Infectious' transplantation tolerance. Science 259, 974-977.
56. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302. (Pubitemid 30470312)
57. Reape, K.Z., DiLiberti, C.E., Hendy, C.H., et al. (2008). Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive. Contraception 77, 34-39.
58. Rifkin, D.B. (2005). Latent transforming growth factor-beta (TGF-beta) binding proteins: Orchestrators of TGF-beta availability. J. Biol. Chem. 280, 7409-7412. (Pubitemid 40349631)
59. Roberts, A.B., Anzano, M.A., Lamb, L.C., et al. (1981). New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues. Proc. Natl Acad. Sci. USA 78, 5339-5343. (Pubitemid 12248581)
60. Rubtsov, Y.P., Niec, R.E., Josefowicz, S., et al. (2010). Stability of the regulatory T cell lineage in vivo. Science 329, 1667-1671.
61. Sakaguchi, S., Sakaguchi, N., Asano, M., et al. (1995). Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alphachains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164.
62. Sakaguchi, S., Wing, K., Onishi, Y., et al. (2009). Regulatory T cells: How do they suppress immune responses? Int. Immunol. 21, 1105-1111.
63. + regulatory T cell activity: It takes (IL-)two to tango. Eur. J. Immunol. 35, 1336-1341. (Pubitemid 40691414)
64. + Treg cells on Th1 differentiation requires cell-cell contact partially via TGF-beta production. Cell Biol. Int. 35, 705-712.
65. + T regulatory cell-mediated suppression. Immunity 30, 636-645.
66. Shevach, E.M. (2011). The resurrection of T cell-mediated suppression. J. Immunol. 186, 3805-3807.
67. Shevach, E.M., Tran, D.Q., Davidson, T.S., et al. (2008). The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell function. Eur. J. Immunol. 38, 915-917.
68. Shi, Y., and Massague, J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700. (Pubitemid 36724933)
69. Shi, M., Zhu, J., Wang, R., et al. (2011). Latent TGF-beta structure and activation. Nature 474, 343-349.
70. Shull, M.M., Ormsby, I., Kier, A.B., et al. (1992). Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
71. Stockis, J., Colau, D., Coulie, P.G., et al. (2009). Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur. J. Immunol. 39, 3315-3322.
72. Takimoto, T., Wakabayashi, Y., Sekiya, T., et al. (2010). Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development. J. Immunol. 185, 842-855.
73. + regulatory T cell: A jack of all trades, master of regulation. Nat. Immunol. 9, 239-244. (Pubitemid 351267321)
74. + T regulatory cells. J. Immunol. 184, 3433-3441.
75. Tone, Y., Furuuchi, K., Kojima, Y., et al. (2008). Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9, 194-202.
76. + regulatory T cells and their interactions with dendritic cells. Hum. Immunol. 70, 294-299.
77. + regulatory T cells. Proc. Natl Acad. Sci. USA 106, 13445-13450.
78. + regulatory T cell suppressor function. J. Immunol. 182, 2929-2938.
79. Travis, M.A., Reizis, B., et al. (2007). Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449, 361-365. (Pubitemid 47443473)
80. + T cells in gut Peyer's patches. Science 323, 1488-1492.
81. Veldhoen, M., Hocking, R.J., Atkins, C.J., et al. (2006). TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189. (Pubitemid 43214587)
82. Veldhoen, M., Uyttenhove, C., van Snick, J., et al. (2008). Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341-1346.
83. Vokaer, B., van Rompaey, N., Lemaitre, P.H., et al. (2010). Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. J. Immunol. 185, 3417-3425.
84. Volpe, E., Servant, N., Zollinger, R., et al. (2008). A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nat. Immunol. 9, 650-657. (Pubitemid 351712635)
85. Wahl, S.M. (2007). Transforming growth factor-beta: Innately bipolar. Curr. Opin. Immunol. 19, 55-62. (Pubitemid 46073697)
86. Wahl, S.M., Hunt, D.A., Wong, H.L., et al. (1988). Transforming growth factorbeta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol. 140, 3026-3032.
87. Wahl, S.M., Wen, J., et al. (2006). The kiss of death: Interrupted by NK-cell close encounters of another kind. Trends Immunol. 27, 161-164.
88. Wang, H., Peters, T., Sindrilaru, A., et al. (2008a). TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis. J. Clin. Invest. 118, 2629-2639. (Pubitemid 351949790)
89. Wang, R., Wan, Q., Kozhaya, L., et al. (2008b). Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS One 3, e2705.
90. - T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 178, 6725-6729. (Pubitemid 46847395)
91. Yang, Z., Mu, Z., Dabovic, B., et al. (2007). Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J. Cell Biol. 176, 787-793. (Pubitemid 46425539)
92. - cells to develop suppressive activity: The role of IL-2, TGF-beta, and IL-10. J. Immunol. 172, 5213-5221. (Pubitemid 38542018)
93. Zheng, Y., Josefowicz, S., Chaudhry, A., et al. (2010). Role of conserved noncoding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808-812.
94. H17 cell differentiation by antagonizing RORgammat function. Nature 453, 236-240. (Pubitemid 351667978)
95. + T cell lineage differentiation. Immunity 30, 646-655.
96. Zhou, X., Bailey-Bucktrout, S.L., Jeker, L.T., et al. (2009b). Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007.